A 700 (see companion bill S 2919) – New York
Status: Inactive / DeadYear Introduced: 2017
Link: https://assembly.state.ny.us/leg/?default_fld=&bn=A00700&term=2017&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y
Relates to prescription drugs in Medicaid managed care programs. The managed care provider shall develop its preferred drug list based initially on an evaluation of the clinical effectiveness, safety, and patient outcomes, followed by consideration of the cost-effectiveness of the drugs.
Key Issues:
Medicaid Pharmaceuticals
PHARMACEUTICALS
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found